Profile

ImmunoBiochem is an immuno-oncology biopharmaceutical company that has developed a disruptive approach to targeting unique proteins amplified in cancer secretomes. This differentiated approach enables the selective and efficacious delivery of immunomodulatory and chemotherapeutic payloads into tumour cells, immune cells and tumour-supporting stroma within the tumour microenvironment. ImmunoBiochem has developed several biological therapeutics lead molecules for the treatment of various intractable solid tumours.

Event details

Date: January 9 - 11, 2023

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

13 in total
  • AmacaThera
    AmacaThera is a clinical-stage biotechnology company transforming therapeutics to make a difference in patient health.…
  • Caladria Therapeutics Inc.
    Caladria is a precision neuromedicine company focused on using an unbiased human data-driven approach to discover and…
  • Cloud DX
    Cloud DX provides award-winning Virtual Care and Remote Patient Monitoring (RPM) solutions to…
  • ImmunoBiochem Corporation
    ImmunoBiochem is an immuno-oncology biopharmaceutical company that has developed a disruptive approach to targeting…
  • Mannin Research
    Mannin Research Inc. is a Canadian private biotechnology company, headquartered in Toronto, Ontario. It is developing…
  • Mediphage Bioceuticals
    Mediphage is developing safe and re-dosable non-viral gene therapies based on its proprietary linear, covalently closed…
  • Nucro-Technics
    Nucro-Technics is a full-service Contract Support Organization that specializes in the conduct of both…
  • ProteinQure
    ProteinQure is a computational platform for protein drug discovery that partners with pharma to deliver experimentally…
  • QurCan Therapeutics
    QurCan Therapeutics is a biotech company focused on developing next-generation RNA and chemotherapeutics…
  • Quthero
    Quthero aims to disrupt skin care after dermatological procedures, such as laser skin resurfacing and microneedling,…
  • Rapid Novor
    Rapid Novor helps researchers decode immunity so they can rapidly and effortlessly develop diagnostics, therapies,…
  • Spiderwort
    Spiderwort is a biomaterials company developing a platform of biocompatible, versatile, cellulose-based scaffolds for…
  • Tenomix
    Tenomix’s mission is to develop novel technologies that target inefficiencies in the pathology workflow, optimize…